BOSTON, July 28, 2022 /PRNewswire/ — Diagnostic Robotics, a leading provider of Artificial Intelligence & Care Management solutions for Healthcare plans and providers, today announced the closing of a $45M Series B funding round led by StageOne investors, with participation from Mayo Clinic, thus becoming a Mayo Clinic Platform portfolio company. Technion – Israel Institute of Technology, as well as other existing investors. Strategic angel investor Bradley Bloom, co-founder of Berkshire Partners, participated in this funding round as well.

hhh hier.